<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>2519164</identifier>
<setSpec>0034-9887</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>García-Ortiz, R</dc:author>
<dc:author>Silva, G</dc:author>
<dc:author>Herrera, O</dc:author>
<dc:author>Gómez, M</dc:author>
<dc:author>Uribe, C</dc:author>
<dc:author>Campos, G</dc:author>
<dc:description xml:lang="en">We studied the effects of indoprofen on urea and creatinine clearance and on protein loss in 6 patients submitted to intermittent peritoneal dialysis. The patients had no evidence of peritonitis. Dialysis fluid contained indoprofen (50 mg/l) or no drug. Mean protein loss into dialysis solution was 51.2 g without and 44.7 g with indoprofen (NS). Urea clearance was 33.3 and 33.6 ml/min and creatinine clearance 24.7 and 36.0 ml/min, respectively (NS). Levels of PGF2 alpha in the dialysate, measured in 2 subjects, were not affected by indoprofen. These results suggest that prostaglandins are not the main factors involved in control of urea and creatinine clearance and protein loss during intermittent peritoneal dialysis.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>1989 May </dc:date>
<dc:title xml:lang="es">Indoprofeno en peritoneo diálisis crónica intermitente: efectos en ladepuración de moleculas pequeñas y perdida de proteinas.</dc:title>
<dc:title xml:lang="en">[Indoprofen in chronic intermittent peritoneal dialysis: effects in the clearance of small molecules and protein loss].</dc:title>
<dc:publisher>Revista medica de Chile</dc:publisher>
</metadata>
</record>
</pubmed-document>
